KHKaren Ruben Husby

Karen Ruben Husby

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karen Ruben Husby has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Manchester procedure: A systematic review of recurrence, perioperative measures, and financial cost, and a scoping review of sexual dysfunction, gynecologic cancer, and obstetric outcomes

    by Sophia Elissaoui, Meryam El Issaoui, Niels Klarskov, Karen Husby

    Introduction: The Manchester procedure (MP) is increasingly used to treat uterine prolapse. This combined systematic and scoping review aims to comprehensively evaluate clinical outcomes of the MP in comparison with other surgical techniques for uterine prolapse. Material and Methods: PRISMA guidelines were applied for the systematic part of the review and PRISMA‐ScR guidelines for the scoping part. PubMed and Embase were searched up to September 30, 2024. The study population comprised women >18 years undergoing MP or other surgical treatments for uterine prolapse. The primary outcome was recurrence of pelvic organ prolapse defined as anatomical or subjective recurrence or reoperation. Secondary outcomes were surgical and operative complications, operative outcome, lower urinary tract symptoms, sexual dysfunction, quality of life and satisfaction, gynecological cancer, obstetric outcome, and financial costs. Data collection was carried out as per PRISMA and PRISMA‐ScR guidelines. Quality of the randomized clinical trials was assessed by the Cochrane risk of bias tool and non‐randomized studies were assessed using the Newcastle–Ottawa Scale. PROSPERO (no.: CRD42024551520). Results: A total of 19 articles were included: 11 were eligible for the systematic review and 11 for the scoping review, with three articles overlapping. Large cohort studies and one randomized controlled trial demonstrated lower risks of prolapse recurrence and reoperation following the MP compared with alternative surgical approaches. Blood loss, organ injury, and overall surgical complication rates were low across all procedures. Operative time and length of hospital stay were shorter after the MP than after vaginal hysterectomy and comparable to sacrospinous hysteropexy. Cost analyses showed significantly lower costs associated with the MP. Sexual function and dyspareunia outcomes were generally comparable between procedures. Cervical stenosis and risk of cancer after MP is low, with no evidence of increased gynecological cancer incidence or worse prognosis compared with anterior colporrhaphy for cystocele. Due to limited and concerning data on pregnancy outcomes, the MP should be reserved for women who have completed childbearing. Conclusion: Despite limited high‐quality evidence, the existing literature supports the MP as a clinically effective and cost‐efficient uterus‐preserving surgical option for uterine prolapse.


  • Mesh Exposure After Mid-urethral Slings. A National Observational Study of 9 Years of Practice in Denmark

    by Karen Ruben Husby, Maria Ferm Eisenhardt, Thomas Bergholt, Kim Oren Gradel, Niels Klarskov

    Stress urinary incontinence is a common condition that significantly affects women's quality of life. Minimally invasive mid-urethral slings are the gold standard treatment, offering high cure rates and low complication risks. Although rare, mesh exposure can cause debilitating pain, making prevention essential. Infection may contribute to mesh exposure, but evidence supporting prophylactic antibiotic use is limited. We hypothesized that a single perioperative dose of antibiotics reduces the risk of mesh exposure and that exposure rates differ between retropubic (R-MUS) and transobturator (tO-MUS) sling approaches. We included Danish women undergoing primary mid-urethral sling surgery from 2010 to 2018 using nationwide registry data. Cox's regressions were used to assess the risk of mesh exposure by perioperative antibiotic use and sling type. Among 6706 women, 3991 underwent R-MUS and 2715 tO-MUS, hereof 34 (0.9%) and 53 (2.0%), respectively, experienced mesh exposures; 5178 (77.2%) received perioperative antibiotics, 82% in the R-MUS and 70% in the tO-MUS group. Mesh exposure occurred in 30 (1.6%) patients with antibiotics vs. 23 (2.9%) without. Perioperative antibiotics reduced mesh exposure in the tO-MUS group (adjusted hazard ratio (aHR) 0.5 [95% confidence interval (CI) 0.3-0.9])), whereas the pooled R-MUS/tO-MUS analysis was nonsignificant (aHR 0.77 [95% CI 0.45-1.32]). In the R-MUS group, the effect remained inconclusive due to low precision. R-MUS was associated with a significantly lower risk of mesh exposure compared to tO-MUS (aHR 0.5 [95% CI 0.3-0.7]). Perioperative antibiotics were linked to reduced mesh exposure after tO-MUS. R-MUS had a lower mesh exposure risk than tO-MUS.

  • Colpocleisis: reoperation risk and risk of uterine and vaginal cancer: A nationwide cohort study

    by Marie Hammerbak-Andersen, Niels Klarskov, Karen R. Husby

    Introduction and hypothesis We aimed to evaluate the risk of reoperation and uterine (myometrial, endometrial, and cervical) and vaginal cancer after colpocleisis performed during the years 1977–2018. Furthermore, we also aimed to assess the development in colpocleisis procedures performed during the study period. Methods Danish nationwide registers covering operations, diagnoses, and life events can be linked on an individual level owing to the unique personal numbers of all Danish residents. We performed a nationwide historical cohort study including women born before year 2000 who underwent colpocleisis between 1977 and 2018 (N = 2,228) using the Danish National Patient Registry (DNPR). We followed the cohort until death/emigration/31 December 2018, whichever came first. Primary outcomes were number of pelvic organ prolapse (POP) operations performed after colpocleisis and uterine and vaginal cancer diagnosed after colpocleisis in a subgroup of women with the uterus in situ. This was assessed with cumulative incidences. Results During follow-up (median 5.6 years) 6.5% and 8.2% underwent POP surgery within 2 and 10 years after colpocleisis respectively. Within 10 years after colpocleisis 0.5% (N = 8) were diagnosed with uterine or vaginal cancer in the subgroup of women with their uterus (N = 1,970). During the study time 37–80 women underwent colpocleisis yearly and the mean age increased (77.1 to 81.4 years). Conclusion Despite smaller studies showing no recurrence after colpocleisis, we found that 6.5% underwent reoperation within 2 years. Few women were diagnosed with uterine or vaginal cancer after colpocleisis. The increased age at the time of colpocleisis indicates changed attitudes regarding surgical treatment for elderly women with comorbidities.


  • Open Access

    Hysterectomy on benign indication and risk of pelvic organ prolapse surgery: A national matched cohort study

    by Andreas Höier Aagesen, Niels Klarskov, Kim Oren Gradel, Karen Ruben Husby

    Introduction: Hysterectomy is a frequently performed gynecological procedure but long‐term effects remain understudied. Pelvic organ prolapse reduces life quality significantly. The lifetime risk of undergoing pelvic organ prolapse surgery is 20% and parity is known to be the largest risk factor. Studies have shown an increased risk of pelvic organ prolapse surgery after hysterectomy; however, few have studied the compartments which are affected and how this association is affected by surgical route and parity.Material and methods: In this Danish nationwide cohort study, we identified women born in 1947–2000 who underwent hysterectomy during 1977–2018 who were indexed on the day of hysterectomy. We excluded women who immigrated when older than 15 years, who underwent pelvic organ prolapse surgery prior to index, and who were diagnosed with a gynecological cancer prior to or within 30 days of index. Women who underwent hysterectomy were matched 1:5 to references on age and year of hysterectomy. Women were censored at the time of death, emigration, a gynecological cancer diagnosis, radical or unspecified hysterectomy or December 31, 2018, whichever came first. The risk of pelvic organ prolapse surgery after hysterectomy was computed using Cox proportional hazard ratios (HRs) with 95% confidence intervals (CIs), adjusted for age, calendar year, parity, income and educational level.Results: We included 80 444 women who underwent hysterectomy and 396 303 reference women. Women who underwent hysterectomy had a significantly higher risk of undergoing pelvic organ prolapse surgery: HRadjusted 1.4 (95% CI 1.3–1.5). In particular, the risk of a posterior compartment prolapse operation was increased: HRadjusted 2.2 (95% CI 2.0–2.3). The risk of prolapse surgery increased with increased parity and by an additional 40% after hysterectomy. Cesarean sections did not seem to increase the risk of prolapse surgery.Conclusions: This study shows that hysterectomy, regardless of surgical route, leads to an increased risk of pelvic organ prolapse surgery, especially in the posterior compartment. The risk of prolapse surgery increased with the number of vaginal births, and not cesarean sections. Women should be thoroughly informed about the risk of pelvic organ prolapse and other treatment options should be considered before choosing hysterectomy to treat benign gynecological diseases –particularly women who have had numerous vaginal births.


  • Cervical cancer after the Manchester procedure: a nationwide cohort study

    by Karen R. Husby, Kim O. Gradel, Niels Klarskov

    Introduction and hypothesis The Manchester procedure is a successful operation to treat uterine prolapse. However, the influence on cervical cancer remains unknown. We hypothesized a lower risk of cervical cancer after the Manchester procedure. Methods We included all Danish women undergoing the Manchester procedure during 1977–2018 (N = 23,935). Women undergoing anterior colporrhaphy (N = 51,008) were included as references due to comparable health-seeking behaviors. The study cohort is as previously described. We assessed the risk of cervical cancer mortality after the Manchester procedure versus anterior colporrhaphy using cumulated incidence plots and Cox hazard regressions. We applied Fisher’s exact test to compare the distribution of histological subtypes after the operations. Results Generally, few women were diagnosed with cervical cancer (0.1% after Manchester procedure and 0.2% after anterior colporrhaphy). After the Manchester procedure, the risk of cervical cancer was reduced (HR 0.60 [95% CI 0.39–0.94]). Furthermore, we found a slightly reduced risk of overall death (HR 0.96 [95% 0.94–0.99]), but no association regarding death due to cervical cancer (HR 0.66 [95% 0.34–1.25]). The distribution of histological subtypes was not changed. Conclusions Women undergoing the Manchester procedure are at lower risk of being diagnosed with cervical cancer, while the risk of cancer specific mortality is unchanged compared to women undergoing anterior colporrhaphy. Based on this study, we cannot recommend that women exit ordinary screening programs for human papillomavirus/cervical dysplasia after a Manchester procedure.


  • Stress Urinary Incontinence After Operations for Uterine Prolapse: A Nationwide Cohort Study

    by Karen R. Husby, Kim O. Dvm Gradel, Niels Md Klarskov

    Importance Concomitant surgery for stress urinary incontinence (SUI) during pelvic organ prolapse (POP) operations are debated. Objectives We aimed to assess the risk of an SUI operation after a uterine prolapse operation and compare the risk after the Manchester procedure versus vaginal hysterectomy. Study Design We performed a nationwide historical cohort study including women with no history of hysterectomy undergoing the Manchester procedure (n = 6065) or vaginal hysterectomy (n = 9,767) for POP during 1998 to 2018. We excluded women with previous surgery for SUI and POP, concomitant surgery for SUI (n = 34, 0.2%), and diagnosed with gynecological cancer before or within 90 days from surgery. Women were followed up until SUI operation/death/emigration/diagnosis of gynecological cancer/December 31, 2018, whichever came first. Women undergoing the Manchester procedure were censored if they had undergone hysterectomy. We assessed the rate of SUI surgery with cumulative incidence plots. We performed Cox Regression to analyze the risk of SUI surgery, adjusting for age, calendar year, income level, concomitant surgery in anterior and posterior compartments, and diagnosis of SUI before POP operation. Results We found that 12.4% women with and 1.6% without SUI diagnosed before the POP surgery who underwent SUI surgery within 10 years. During follow-up (median, 8.5 years), 129 (2.1%) underwent SUI surgery after the Manchester procedure and 175 (1.8%) after vaginal hysterectomy (adjusted hazard ratio, 1.06 [0.84–1.35]). Conclusions Of women diagnosed with SUI before POP operation 1 in 8 subsequently underwent SUI surgery. Few women not diagnosed with SUI subsequently underwent SUI surgery. There was no difference in risk of SUI after the Manchester procedure and vaginal hysterectomy.


  • Reply: The risk of pelvic organ prolapse after hysterectomy

    by Karen R. Husby, Kim O. Gradel, Niels Klarskov